Search results for 'US Generics'

When Modi meets Xi: Few things China can look forward to

When Modi meets Xi: Few things China can look forward to

Rediff.com8 May 2015

India could offer a train track to China to run a bullet train besides easy terms to set up industrial parks.

Meet Deepak Tijori's daughter, Samara

Meet Deepak Tijori's daughter, Samara

Rediff.com5 Apr 2017

Samara is surely Bollywood ready!

Review: Ladies vs Ricky Bahl is sluggish and predictable

Review: Ladies vs Ricky Bahl is sluggish and predictable

Rediff.com9 Dec 2011

By the time the film winds down in extremely simplistic fashion, we just don't care anymore.

India gets an earful from US on affordable healthcare issues

India gets an earful from US on affordable healthcare issues

Rediff.com26 Nov 2014

US said access to affordable health care entails a large number of factors from rates, logistics to insurance reforms.

MNCs campaigning against Indian pharma firms

MNCs campaigning against Indian pharma firms

Rediff.com7 Mar 2011

The government on Monday said that multinational companies (MNCs) are campaigning against domestic pharmaceuticals industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment.

US oral contraceptive market draws Indian pharma

US oral contraceptive market draws Indian pharma

Rediff.com17 Nov 2011

Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.

Vikas? Major Economic Reforms? Naah!

Vikas? Major Economic Reforms? Naah!

Rediff.com18 Dec 2017

'It is clear that economic policy and reform under this administration will always be afterthoughts, something to be carried out only when no other political concern intervenes -- when, in other words, the government feels safe and comfortable enough to take a moderate risk,' argues Mihir S Sharma.

Dr Reddy's to form JV with Fujifilm Corporation

Dr Reddy's to form JV with Fujifilm Corporation

Rediff.com28 Jul 2011

Dr Reddy's Laboratories today said it will form a joint venture with Fujifilm Corporation to develop, manufacture and market generic drugs in Japan.

We will regain confidence of the US FDA: Dilip Shanghvi

We will regain confidence of the US FDA: Dilip Shanghvi

Rediff.com26 Mar 2015

'The focus for value creation will be on all business segments.'

New internet domain names prompt govt meet

New internet domain names prompt govt meet

Rediff.com5 Jul 2011

The Internet Corporation of Assigned Names and Numbers' (ICANN) decision to expand gTLD (generic top-level domain) names on the internet to include almost any name (even .anything), is foxing both users and registers. It has also raised fears of online trademark violations and cybersquatting.

EU clears water for Indian pharma firms

EU clears water for Indian pharma firms

Rediff.com31 Mar 2011

European countries are trying to woo back the Indian customers they had lost following seizure of drug consignments by Customs authorities of several European Union members.

Few takers for Patiala House

Few takers for Patiala House

Rediff.com14 Feb 2011

Trade analyst Vinod Mirani gives us the box office verdict for the week.

'The virus will circulate for a very long time'

'The virus will circulate for a very long time'

Rediff.com10 May 2020

'Despite expanded testing the incidence remains low.' 'Therefore, the focus should be on specific districts where we need to improve the testing.' 'We should have a district-centric strategy.'

IMAGES: 8 simple steps to a great-looking bod!

IMAGES: 8 simple steps to a great-looking bod!

Rediff.com3 Nov 2011

Changing your body type may seem to be difficult, but you can still manage to get it in great shape. You can be the architect of your own body with these eight simple steps!

Big opportunities opening up for Cipla

Big opportunities opening up for Cipla

Rediff.com3 Sep 2014

Respiratory product paves way for launch in larger markets and greater earnings visibility.

Lupin settles patent suit with Medicis, signs pact

Lupin settles patent suit with Medicis, signs pact

Rediff.com25 Jul 2011

The pact would entail the Indian company receiving up to $38 million (over Rs 165 crore).

Abbott adds local expertise to its global resource

Abbott adds local expertise to its global resource

Rediff.com11 Jan 2011

Antacid Digene and pain drug Brufen have been among the top in their categories in India for decades. But not their manufacturer, Abbott.

New hopes for Ranbaxy to grab Lipitor pie

New hopes for Ranbaxy to grab Lipitor pie

Rediff.com8 Apr 2011

Ranbaxy's hope of a windfall from the $7-billion Lipitor market in the US is shining again. The US Food and Drugs Administration (USFDA) has taken a strong stance against US-based Mylan, which had opposed FDA's decision to allow approval to Ranbaxy's generic version of Lipitor.

Aurbindo Pharma inks deal with AstraZeneca

Aurbindo Pharma inks deal with AstraZeneca

Rediff.com6 Sep 2010

Drugmaker Aurobindo Pharma on Monday said it has entered into licensing and supply agreements with London-based pharmaceutical giant AstraZeneca to supply several solid dosage and sterile products for emerging markets.

EU, India to solve dispute over drug seizures

EU, India to solve dispute over drug seizures

Rediff.com9 Dec 2010

In the clearest indication from the European Commission yet that a resolution to the ongoing dispute between New Delhi and Brussels regarding generic drug seizures had been reached, a senior EC official told reporters on Wednesday that the EU was "open to changing" the offending regulation.

Dr Reddy's expands its US horizon

Dr Reddy's expands its US horizon

Rediff.com29 Nov 2010

Already having a deal with GlaxoSmithKline for marketing its products in various emerging markets, Dr Reddy's Laboratories had this week inked an agreement to buy the latter's oral penicillin manufacturing facility at Tennessee in the United States.

Natco challenges Gilead's patent on Tamiflu

Natco challenges Gilead's patent on Tamiflu

Rediff.com9 Feb 2011

The company has sought the United States Food and Drug Administration (FDA)'s approval to market a generic version of Tamiflu (oseltamivir phosphate), said Gilead Sciences, the US company that owns the Tamiflu patent. Natco officials declined to comment on the development.

Road to 70: Five brands that grew with India and on Indians

Road to 70: Five brands that grew with India and on Indians

Rediff.com16 Aug 2016

Pond's, Parle-G, Cadbury, Asian Paints and Amul have captured the changing face of India through the seven decades

Voting begins in crucial midterm polls in US

Voting begins in crucial midterm polls in US

Rediff.com7 Nov 2018

According to political pundits, the Democrats have a good chance of winning the House, while the Republicans are likely to retain the Senate.

 India to move WTO panel against EU

India to move WTO panel against EU

Rediff.com1 Oct 2010

India may formally approach the World Trade Organisation's dispute panel against the European Union following the seizure of low-cost generic medicine consignments in European ports meant for other developing countries. The two parties have failed to reach an amicable solution during the consultation process.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Merck arm sues Sun over cancer drug

Merck arm sues Sun over cancer drug

Rediff.com21 Sep 2010

Merck arm sues Sun over cancer drugSchering Corporation, part of multinational pharma company Merck & Co, and London-based Cancer Research Technology Ltd have sued Sun Pharmaceutical for allegedly infringing patent rights on the world's largest selling brain cancer drug, Temodar.

Large co-op banks may come under Banking Act

Large co-op banks may come under Banking Act

Rediff.com16 Dec 2019

Large urban co-operative banks may come to be solely under the provisions of the Banking Regulation Act, even as the smaller among them are to remain within the exclusive fold of the Registrar of Co-operative Societies. The upcoming changes will bring the curtains down on the vexed issue of dual control of UCBs, which has been in vogue for 54 years. The new framework will affect 1,551 UCBs in the country, which had a total business of Rs 7.36 trillion.

Samsung Galaxy A7: Is this Samsung Galaxy S7's poor cousin?

Samsung Galaxy A7: Is this Samsung Galaxy S7's poor cousin?

Rediff.com8 Sep 2017

And should you buy it for Rs 33,490? Uttaran Das Gupta has the answers.

Glenmark may become first Indian firm with NCE

Glenmark may become first Indian firm with NCE

Rediff.com9 Nov 2010

Glenmark and its partners today said Crofelemer, a first-in-class (first of its kind) anti-diarrhoeal drug for HIV-associated diarrhoea, had successfully completed the third and final phase of clinical trials.

Hospira buys Orchid unit for $400 mn

Hospira buys Orchid unit for $400 mn

Rediff.com16 Dec 2009

US-based drug major Hospira will buy the injectable pharmaceuticals business of Chennai-based Orchid Chemicals for $400 million (Rs 1,860 crore).

Wockhardt receives US nod for cardiac drug

Wockhardt receives US nod for cardiac drug

Rediff.com23 Jul 2010

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.

 Why European Union seizes Indian drugs

Why European Union seizes Indian drugs

Rediff.com1 Nov 2010

India's status as the pharmacy of the world is at stake.

Dear women, want advice on personal finance? Send in your questions!

Dear women, want advice on personal finance? Send in your questions!

Rediff.com19 Aug 2019

Hena Mehta will answer Your Questions on personal finance on a weekly basis. Please mail your questions to getahead@rediff.co.in with the subject line 'Personal Finance Query' along with your name and Hena will offer his helpful advice.

3 useful tips to ace APPRAISALS in 2020

3 useful tips to ace APPRAISALS in 2020

Rediff.com16 Jan 2020

Workplace mentoring helps young professionals understand their work, encourages them to perform more effectively and gives the motivation to do better work, says Ambrish Sinha.

Mahindra raids auto part makers to counter fake products

Mahindra raids auto part makers to counter fake products

Rediff.com29 Jan 2015

M&M conducted raids across six auto spare part makers and sales outlets.

Ranbaxy launches heart disease drug in India

Ranbaxy launches heart disease drug in India

Rediff.com10 Jun 2010

Ranbaxy Laboratories on Thursday launched a generic version of Prasugrel, used in treating heart diseases, from Daiichi Sankyo portfolio in India as part of strategy to launch drugs from the parent company's stable.

Dr Reddy's net profit up 7.4%, lags estimates

Dr Reddy's net profit up 7.4%, lags estimates

Rediff.com30 Jul 2013

The Hyderabad-based drugmaker said consolidated net profit rose to Rs Rs 361 crore (Rs 3.61 billion) for the fiscal first quarter ended June, from Rs 336 crore (Rs 3.36 billion) a year earlier.

Sun-Ranbaxy merger clears last hurdle

Sun-Ranbaxy merger clears last hurdle

Rediff.com10 Mar 2015

On January 31, the US Federal Trade Commission cleared the merger.